Medical and Science
Perspectives from one Australian team’s search for a COVID-19 vaccine

Medical News: While it may not be here tomorrow, scientists around the world are racing to develop viable COVID-19 vaccine candidates.
In this podcast episode, two Australian researchers from The University of Queensland share how their team identified a lead vaccine candidate from an initial field of 200 in just over 5 weeks.

Dodi Axelson, Head of Communications, Cytiva, Sweden and Conor McKechnie, Vice President Marketing, Cytiva, United Kingdom share the perspectives of:
- Trent Munro, Professor & Senior Group Leader at the Australian Institute for Bioengineering Nanotechnology and
- Keith Chappell, Associate Professor & Affiliate Senior Research Fellow at the Australian Institute for Bioengineering and Nanotechnology from The University of Queensland.
Discovery Matters is a collection of stories and insights on matters of discovery that advance science and medicines. Brought to you by the curious people at Cytiva.
News - Pharmaceuticals
New funding to bring global CAR-T trials to young cancer patients
The government is delivering the first investment under the $300 million MRFF Australian Cancer Research Program (ACRP), to bring international […]
MoreNews - Pharmaceuticals
Rising gynae cancers meets a system forcing patients to pay the price
Sector leaders, government and women with lived experience unite in Canberra today to accelerate evidence-based action, as gynaecological cancer diagnoses […]
MoreNews - MedTech & Diagnostics
Analysis confirms private health insurance cuts target vulnerable pensioners
New analysis by the Parliamentary Budget Office (PBO) shows that half of the $3 billion dollars the Albanese Government expects […]
MoreNews - MedTech & Diagnostics
Chalmers retreats as startup tax backlash forces further changes
The Albanese Government has been forced to retreat from several of the most contentious elements of its proposed startup tax […]
More